These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 15897160

  • 1. Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial.
    Dall'oglio F, Nasca MR, Musumeci ML, La Torre G, Ricciardi G, Potenza C, Micali G.
    J Dermatolog Treat; 2005 Feb; 16(1):10-4. PubMed ID: 15897160
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
    Ajith C, Gupta S, Kanwar AJ.
    J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260
    [Abstract] [Full Text] [Related]

  • 3. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
    Inui S, Nakajima T, Toda N, Itami S.
    J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
    [Abstract] [Full Text] [Related]

  • 4. Topical immunotherapy of alopecia areata. A follow-up study.
    Valsecchi R, Cainelli T, Foiadelli L, Rossi A.
    Acta Derm Venereol; 1986 Jun; 66(3):269-72. PubMed ID: 2426909
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S, Freyschmidt-Paul P, Hoffmann R, Sundberg JP, Happle R, Lindsey NJ, Tobin DJ.
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [Abstract] [Full Text] [Related]

  • 7. Alopecia areata: a long term follow-up study of 191 patients.
    Tosti A, Bellavista S, Iorizzo M.
    J Am Acad Dermatol; 2006 Sep; 55(3):438-41. PubMed ID: 16908349
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of alopecia areata with squaric acid dibutylester.
    Hill ND, Bunata K, Hebert AA.
    Clin Dermatol; 2015 Sep; 33(3):300-4. PubMed ID: 25889130
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P, Sundberg JP, Happle R, McElwee KJ, Metz S, Boggess D, Hoffmann R.
    J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
    [Abstract] [Full Text] [Related]

  • 16. Modified immunotherapy for alopecia areata.
    Yoshimasu T, Furukawa F.
    Autoimmun Rev; 2016 Jul; 15(7):664-7. PubMed ID: 26932732
    [Abstract] [Full Text] [Related]

  • 17. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
    Morita K, Nakamura M, Nagamachi M, Kishi T, Miyachi Y.
    J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.